Research Tool
Enter vial mass and diluent volume to calculate stock-solution concentration in mg/mL.
This 1:1 blend contains retatrutide 5mg + cagrilintide 5mg, 10mg total. In a 2 mL arithmetic example, total concentration is 5 mg/mL and each component is 2.5 mg/mL.
Total mg of lyophilized Retatrutide + Cagrilintide in the vial
Volume of diluent added to the vial
The amount you want in each syringe draw
Syringe size
Concentration
5
mg/mL (equal to µg/µL)
Same concentration
5,000
µg/mL
Concentration (mg/mL) = peptide mass (mg) ÷ diluent volume (mL). For in-vitro laboratory research use only.
Enter an amount per draw to see the syringe units, volume and draws per vial.
| Component | mg in vial | mg/mL |
|---|---|---|
| Retatrutide | 5 | 2.5 |
| Cagrilintide | 5 | 2.5 |
Component amounts are nominal fill amounts. A lot's measured content is listed on its certificate of analysis.
Lyophilized research material, shipped from Phoenix, AZ.
Get an email when we publish a new lot certificate or restock. Unsubscribe anytime.
Record the compound, mass, diluent volume, concentration, date prepared and optional lot.
Nothing typed here leaves your browser.
The 5mg + 5mg (1:1) composition applies only to this listing. In 5 mL, the same vial gives 2 mg/mL total and 1 mg/mL of each component.
Default values are arithmetic examples, not preparation recommendations. For in-vitro lab work.
Each value is the total vial mass divided by the diluent volume, in mg/mL. These are arithmetic examples, not preparation recommendations.
| Vial | 1 mL | 2 mL | 3 mL | 5 mL |
|---|---|---|---|---|
| 10 mg | 10 | 5 | 3.33 | 2 |
This article summarizes publicly available research for educational purposes and does not constitute medical advice, a therapeutic claim, or a recommendation for human use. Products referenced are sold for laboratory research use only.